The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases
Open accessAbstract
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis are complex disorders with undetermined etiology. Several hypotheses suggest that IBDs result from an abnormal immune response against endogenous flora and luminal antigens in genetically susceptible individuals. The dysfunction of the mucosal immune response is implicated in the pathogenesis of IBD. The balance between pro-inflammatory cytokines [tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-8, and IL-17A], anti-inflammatory cytokines (IL-4 and IL-13), and immunoregulatory cytokines (IL-10 and transforming growth factors β) is disturbed. Moreover, evidence from animal and clinical studies demonstrate a positive correlation between an increased concentration of nitric oxide (NO) and the severity of the disease. Interestingly, proinflammatory cytokines are involved in the up-regulation of inducible oxide synthase (iNOS) expression in IBD. However, anti-inflammatory and immunoregulatory cytokines are responsible for the negative regulation of iNOS. A positive correlation between NO production and increased pro-inflammatory cytokine levels (TNF-α, IL-6, IL-17, IL-12, and interferon-γ) were reported in patients with IBD. This review focuses on the role of cytokines in intestinal inflammation and their relationship with NO in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Nitric oxide synthases: Roles, tolls, and controls
Nathan, C., & Xie, Q.-W. (1994) · Cell · doi:10.1016/0092-8674(94)90266-6 · Cited by 2,918
Nitric oxide synthases in mammals
Knowles, R. G., & Moncada, S. (1994) · Biochemical Journal · doi:10.1042/bj2980249 · Cited by 2,752
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
TNF-mediated inflammatory disease
Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094
Nitric oxide: A cytotoxic activated macrophage effector molecule
Hibbs, J. B., Taintor, R. R., Vavrin, Z., & Rachlin, E. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80015-9 · Cited by 2,030
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Immunopathogenesis of IBD: current state of the art
de Souza, H. S. P., & Fiocchi, C. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.186 · Cited by 1,551
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E., Butterfield, D. A., & Giuffrida Stella, A. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2214 · Cited by 1,543
IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
iNOS-mediated nitric oxide production and its regulation
Aktan, F. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.10.042 · Cited by 1,359
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,023
Benson, M. J., Pino-Lagos, K., Rosemblatt, M., & Noelle, R. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070719 · Cited by 847
Rimoldi, M., Chieppa, M., Salucci, V., Avogadri, F., Sonzogni, A., Sampietro, G. M., Nespoli, A., Viale, G., Allavena, P., & Rescigno, M. (2005) · Nature Immunology · doi:10.1038/ni1192 · Cited by 816
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
The role of nitric oxide in innate immunity: NO in innate immunity
Bogdan, C., Röllinghoff, M., & Diefenbach, A. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917307.x · Cited by 662
Singer, II, Kawka, D., Scott, S., Weidner, Jr., Mumford, R., Riehl, T., & Stenson, W. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70055-0 · Cited by 584
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle
Kolios, G., Valatas, V., & Ward, S. G. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01984.x · Cited by 541
Interactions Between the Host Innate Immune System and Microbes in Inflammatory Bowel Disease
Abraham, C., & Medzhitov, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.012 · Cited by 535
Mammalian Nitric Oxide Synthases
Stuehr, D. J., & Griffith, O. W. (1992) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470123119.ch8 · Cited by 508
Parronchi, P., Romagnani, P., Annunziato, F., Sampognaro, S., Becchio, A., Giannarini, L., Maggi, E., Pupilli, C., Tonelli, F., & Romagnani, S. (1997) · Europe PMC (PubMed Central) · Cited by 482
Biology and significance of the JAK/STAT signalling pathways
Kiu, H., & Nicholson, S. E. (2012) · Growth Factors · doi:10.3109/08977194.2012.660936 · Cited by 470
Fehérvari, Z., & Sakaguchi, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423395 · Cited by 452
IL-6 is required for the development of Th1 cell-mediated murine colitis
Yamamoto, M., Yoshizaki, K., Kishimoto, T., & Ito, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4878 · Cited by 411
Bioactive IL-18 Expression Is Up-Regulated in Crohn’s Disease
Monteleone, G., Trapasso, F., Parrello, T., Biancone, L., Stella, A., Iuliano, R., Luzza, F., Fusco, A., & Pallone, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.143 · Cited by 398
Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective
Weaver, C. T., & Hatton, R. D. (2009) · Nature Reviews Immunology · doi:10.1038/nri2660 · Cited by 395
Rachmilewitz, D., Stamler, J. S., Bachwich, D., Karmeli, F., Ackerman, Z., & Podolsky, D. K. (1995) · Gut · doi:10.1136/gut.36.5.718 · Cited by 365
Differential regulation of interleukin 17 and interferon production in inflammatory bowel disease
Rovedatti, L., Kudo, T., Biancheri, P., Sarra, M., Knowles, C. H., Rampton, D. S., Corazza, G. R., Monteleone, G., Di Sabatino, A., & MacDonald, T. T. (2009) · Gut · doi:10.1136/gut.2009.182170 · Cited by 338
Etiopathogenesis of inflammatory bowel diseases
Danese, S., & Fiocchi, C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.12.4807 · Cited by 327
Involvement of IL–6 in the pathogenesis of inflammatory bowel disease and colon cancer
Atreya, R., & Neurath, M. F. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:3:187 · Cited by 324
OBERMEIER, F., KOJOUHAROFF, G., HANS, W., SCHÖLMERICH, J., GROSS, V, & FALK, W. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00878.x · Cited by 317
Nitric Oxide in Inflammatory Bowel Disease
Cross, R. K., & Wilson, K. T. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200305000-00006 · Cited by 303
Regulation of Homeostasis and Inflammation in the Intestine
MacDonald, T. T., Monteleone, I., Fantini, M. C., & Monteleone, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.047 · Cited by 263
Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen
Krieglstein, C. F., Cerwinka, W. H., Laroux, F. S., Salter, J. W., Russell, J. M., Schuermann, G., Grisham, M. B., Ross, C. R., & Granger, D. N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1207 · Cited by 252
Kimura, H., Hokari, R., Miura, S., Shigematsu, T., Hirokawa, M., Akiba, Y., Kurose, I., Higuchi, H., Fujimori, H., Tsuzuki, Y., et al. (1998) · Gut · doi:10.1136/gut.42.2.180 · Cited by 250
Sarra, M., Pallone, F., MacDonald, T. T., & Monteleone, G. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21248 · Cited by 249
Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease
Xu, X.-R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i12.3255 · Cited by 245
The Immune Response in Inflammatory Bowel Disease
Brown, S. J., & Mayer, L. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01343.x · Cited by 237
The IL23 axis plays a key role in the pathogenesis of IBD: Figure 1
McGovern, D., & Powrie, F. (2007) · Gut · doi:10.1136/gut.2006.115402 · Cited by 227
Dijkstra, G., Moshage, H., Van Dullemen, H. M., de Jager-Krikken, A., Tiebosch, A. T. M. G., Kleibeuker, J. H., Jansen, P. L. M., & Van Goor, H. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199812)186:4<416::aid-path201>3.0.co;2-u · Cited by 219
IL-10 modulates DSS-induced colitis through a macrophage–ROS–NO axis
Li, B., Alli, R., Vogel, P., & Geiger, T. L. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.103 · Cited by 187
Role of nitric oxide in the regulation of T cell functions
Niedbala, W., Cai, B., & Liew, F. Y. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058446 · Cited by 181
Nitric oxide and cardiovascular control
Calver, A., Collier, J., & Vallance, P. (1993) · Experimental Physiology · doi:10.1113/expphysiol.1993.sp003687 · Cited by 174
Implication of TNF-Related Apoptosis-Inducing Ligand in Inflammatory Intestinal Epithelial Lesions
Bègue, B., Wajant, H., Bambou, J., Dubuquoy, L., Siegmund, D., Beaulieu, J., Canioni, D., Berrebi, D. D., Brousse, N., Desreumaux, P., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.022 · Cited by 153
Matsuoka, K., Inoue, N., Sato, T., Okamoto, S., Hisamatsu, T., Kishi, Y., Sakuraba, A., Hitotsumatsu, O., Ogata, H., Koganei, K., et al. (2004) · Gut · doi:10.1136/gut.2003.024190 · Cited by 148
T cell–derived inducible nitric oxide synthase switches off TH17 cell differentiation
Yang, J., Zhang, R., Lu, G., Shen, Y., Peng, L., Zhu, C. Y., Cui, M., Wang, W., Arnaboldi, P. M., Tang, M. X., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20122494 · Cited by 145
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut
Caruso, R., Sarra, M., Stolfi, C., Rizzo, A., Fina, D., Fantini, M. C., Pallone, F., MacDonald, T. T., & Monteleone, G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.049 · Cited by 141
Rovedatti, L., Sabatino, A. D., Kudo, T., Biancheri, P., Sarra, M., Monteleone, G., Corazza, G. R., & MacDonald, T. T. (2009) · Digestive and Liver Disease · doi:10.1016/s1590-8658(09)60019-0 · Cited by 131
Nitric oxide as a potential biomarker in inflammatory bowel disease
Avdagić, N., Začiragić, A., Babić, N., et al. (2013) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2013.2402 · Cited by 119
Innate immune recognition of the indigenous microbial flora
Rakoff-Nahoum, S., & Medzhitov, R. M. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.49 · Cited by 117
Xiong, H., Zhu, C. Y., Li, F., Hegazi, R. A. F., He, K., Babyatsky, M. W., Bauer, A. J., & Plevy, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313416200 · Cited by 113
Th17-Related Cytokines in Inflammatory Bowel Diseases: Friends or Foes?
Monteleone, I., Sarra, M., Pallone, F., & Monteleone, G. (2012) · Current Molecular Medicine · doi:10.2174/156652412800620066 · Cited by 107
Cytokines in inflammatory bowel disease
Beck, P., & Wallace, J. L. (1997) · Mediators of Inflammation · doi:10.1080/09629359791785 · Cited by 103
Toumi, R., Soufli, I., Rafa, H., Belkhelfa, M., Biad, A., & Touil–Boukoffa, C. (2014) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201402700418 · Cited by 96
Self-citationPredonzani, A., Calì, B., Agnellini, A. H., & Molon, B. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.64 · Cited by 95
Microbial-Induced Th17: Superhero or Supervillain?
McGeachy, M. J., & McSorley, S. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201834 · Cited by 84
Rafa, H., Saoula, H., Belkhelfa, M., Medjeber, O., Soufli, I., Toumi, R., de Launoit, Y., Moralès, O., Nakmouche, M., Delhem, N., et al. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0063 · Cited by 81
Self-citationActivation of Phosphatidylinositol 3-Kinase by Interleukin-13
Wright, K. L., Ward, S. G., Kolios, G. C., & Westwick, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12626 · Cited by 80
Jädert, C., Phillipson, M., Holm, L., Lundberg, J. O., & Borniquel, S. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.012 · Cited by 73
van Bezooijen, R. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Bone · doi:10.1016/s8756-3282(00)00457-9 · Cited by 72
Rachmilewitz, D., Eliakim, R., Ackerman, Z., & Karmeli, F. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00409.x · Cited by 49
Soufli, I., Toumi, R., Rafa, H., Amri, M., Labsi, M., Khelifi, L., Nicoletti, F., & Touil–Boukoffa, C. (2015) · Journal of Inflammation · doi:10.1186/s12950-015-0063-6 · Cited by 47
Self-citationAbdelouhab, K., Rafa, H., Toumi, R., Bouaziz, S., Medjeber, O., & Touil–Boukoffa, C. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.641971 · Cited by 43
Self-citationRafa, H., Amri, M., Saoula, H., Belkhelfa, M., Medjeber, O., Boutaleb, A., Aftis, S., Nakmouche, M., & Touil–Boukoffa, C. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0012 · Cited by 40
Self-citationTun, X., Yasukawa, K., & Yamada, K. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.020 · Cited by 40
Gut reactions: immune pathways in the intestine in health and disease
Powrie, F. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100197 · Cited by 9
Cited by
The emerging role of oxidative stress in inflammatory bowel disease
Muro, P., Zhang, L., Li, S., Zhao, Z., Jin, T., Mao, F., & Mao, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1390351 · Cited by 279
Said, M. M., Azab, S. S., Saeed, N. M., & El-Demerdash, E. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0010.8662 · Cited by 65
Fernando, I. P. S., Sanjeewa, K. K. A., Samarakoon, K. W., Lee, W. W., Kim, H.-S., & Jeon, Y.-J. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12628 · Cited by 46
Reichman, H., Moshkovits, I., Itan, M., Pasmanik-Chor, M., Vogl, T., Roth, J., & Munitz, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-07738-z · Cited by 27
Metadata
- Authors
- Soufli, I., Toumi, R., Rafa, H., & Touil-Boukoffa, C.
- Venue
- World Journal of Gastrointestinal Pharmacology and Therapeutics
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 7
- Issue
- 3
- Pages
- 353
- ISSN
- 2150-5349 (ISSN-L)
- OpenAlex
- W2491549472
- Cited by
- 343
- References
- 78
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.